The hearing is before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board in Alexandria, Virginia. The latter team, led by Berkeley's Jennifer Doudna and Vienna's Emmanuelle Charpentier, applied for a CRISPR patent in 2013. The Broad team, led by MIT's Feng Zhang, filed a patent application months later, and became the first to obtain a CRISPR patent in 2014. The Berkeley team has obtained CRISPR patents as well, though the 2013 application has not been granted. The two teams, Broad has said, are not really claiming the same invention at all.

Source: Standard Digital December 06, 2016 04:41 UTC